---
schema_version: "secwatch.filing_event.v1"
accession: "0001438133-22-000037"
form_type: "8-K"
ticker: "TNDM"
cik: "0001438133"
company_name: "TANDEM DIABETES CARE INC"
filed_at: "2022-03-15T23:59:59+00:00"
generated_at: "2026-06-26T22:42:56.564564+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director Douglas A. Roeder not standing for re-election at Tandem's 2022 Annual Meeting

## Summary
- Douglas A. Roeder notified the company on March 11, 2022, of his decision not to stand for re-election.
- Roeder has served on the Board since May 2009; his term as Class III director ends at the 2022 Annual Meeting.
- The departure is not due to any disagreement with the company on operations, policies, or practices.

## SEC filing metadata
- accession: 0001438133-22-000037
- form_type: 8-K
- ticker: TNDM
- cik: 0001438133
- company_name: TANDEM DIABETES CARE INC
- filed_at: 2022-03-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1438133/000143813322000037/0001438133-22-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1438133/000143813322000037/tndm-20220311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001438133-22-000037
- JSON: https://secwatch.observer/filing/0001438133-22-000037.json
- Plain text: https://secwatch.observer/filing/0001438133-22-000037.txt

## Key facts
- Executive change
  Douglas A. Roeder departed as Director at TANDEM DIABETES CARE INC.
  - Action: not stand for re-election
  - Role: Director
  source text: On March 11, 2022, Douglas A. Roeder, notified the Company of his decision not to stand for re-election at the Company’s 2022 Annual Meeting of Stockholders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1438133/000143813322000037/0001438133-22-000037-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.